TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
155,556
|
149,327
|
169,073 |
| Financial expenses |
3,869
|
2,198
|
408 |
| Earnings before taxes |
4,253
|
5,860
|
7,630 |
| EBITDA |
6,002
|
6,192
|
8,096 |
| Total assets |
102,492
|
125,092
|
203,670 |
| Current assets |
96,161
|
117,587
|
188,907 |
| Current liabilities |
60,377
|
77,431
|
95,407 |
| Equity capital |
33,352
|
28,200
|
24,851 |
| - share capital |
1,013
|
946
|
975 |
| Employees (average) |
23
|
18
|
31 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.5%
|
22.5%
|
12.2% |
| Turnover per employee |
6,763
|
8,296
|
5,454 |
| Profit as a percentage of turnover |
2.7%
|
3.9%
|
4.5% |
| Return on assets (ROA) |
7.9%
|
6.4%
|
3.9% |
| Current ratio |
159.3%
|
151.9%
|
198.0% |
| Return on equity (ROE) |
12.8%
|
20.8%
|
30.7% |
| Change turnover |
-4,366
|
-14,665
|
-14,497 |
| Change turnover % |
-3%
|
-9%
|
-8% |
| Chg. No. of employees |
5
|
-13
|
-4 |
| Chg. No. of employees % |
28%
|
-42%
|
-11% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.